PDF(Pubmed)
Abstract：
Benign Prostatic Hyperplasia (BPH) is the most frequent cause of Lower Urinary Tract Symptoms (LUTSs) in elderly populations. Minimally invasive treatments of BPH are safe and effective and are gaining popularity among both professionals and patients. Prostate Artery Embolization (PAE) has proven to be effective in Trans-Urethral Resection of the Prostate (TURP) in terms of prostate volume reduction and LUTS relief. PAE entails the selective catheterization of the prostatic artery and later embolization of distal vessels with beads of various calibers. Universal consensus regarding the ideal particle size is yet to be defined. We retrospectively evaluated 24 consecutive patients (median age: 75 years; range: 59-86 years) treated with PAE at our institution from October 2015 to November 2022. Particles of different sizes were employed; 12 patients were treated with 40-120 µm particles, 5 with 100 µm, 5 with 100-300 µm and 2 with 250 µm. Technical success, defined as selective prostate artery catheterization and controlled release of embolizing beads, was achieved in all patients. Removal vs. retention of the urinary catheter at the first post-procedural urological visit was the main clinical objective. No major peri-procedural complications were recorded, with 56% of patients successfully removing the urinary catheter.
摘要：
良性前列腺增生（BPH）是老年人群下尿路症状（LUTSs）的最常见原因。BPH的微创治疗是安全有效的，并且在专业人士和患者中越来越受欢迎。前列腺动脉栓塞（PAE）已被证明在前列腺体积减小和LUTS缓解方面在经尿道前列腺切除术（TURP）中是有效的。PAE需要对前列腺动脉进行选择性导管插入术，然后用各种口径的珠子栓塞远端血管。关于理想粒度的普遍共识尚未定义。我们回顾性评估了2015年10月至2022年11月在我们机构接受PAE治疗的24例连续患者（中位年龄：75岁；范围：59-86岁）。使用不同大小的颗粒；12例患者接受40-120μm颗粒治疗，5，100µm，5，100-300µm，2，250µm。技术上的成功,定义为选择性前列腺动脉导管插入术和栓塞珠的控制释放，在所有患者中都实现了。移除vs.首次术后泌尿外科访视时留置导尿管是主要临床目标.未记录到严重的围手术期并发症，56%的患者成功拔除导尿管。
